Skip to main content

Advertisement

SpringerLink
Log in

Management of Symptomatic Carotid Disease in 2014

  • Peripheral Vascular Disease (MH Shishehbor, Section Editor)
  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

Extracranial carotid artery stenosis accounts for up to 12 % of stroke, the third leading cause of death in industrialized nations. Carotid stenoses leading to transient or permanent neurologic or retinal symptoms within the preceding 6 months are deemed symptomatic and require prompt noninvasive evaluation and treatment. Preventive medical therapy is standard for symptomatic carotid stenosis and continues to evolve. Landmark trials have proven carotid endarterectomy (CEA) superior to medical therapy for stroke prevention in symptomatic lesions. Modern investigations have proven carotid artery stenting (CAS) non-inferior to CEA, and the strength of the combined data has led to a class I recommendation for CEA or CAS in patients with high grade symptomatic carotid stenosis, provided the risk of perioperative events is acceptable. Evidence-based modern management of symptomatic carotid stenosis is reviewed here.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Centers for Disease Control and Prevention. Prevalence of disabilities and associated health conditions among adults-United States, 1999. MMWR Morb Mortal Wkly Report. 2001;50:120–125.

  2. Heart Disease and Stroke Statistics—2009 Update. Dallas, Texas: American Heart Association; 2009.

  3. Broderick J, Brott T, Kothari R, et al. The Greater Cincinnati / Northern Kentucky Stroke Study: preliminary first-ever and total incidence rates of stroke among blacks. Stroke. 1998;29:415–21.

    Article  CAS  PubMed  Google Scholar 

  4. Sacco RL, Kargman DE, Gu Q, et al. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke. 1995;26:14–20.

    Article  CAS  PubMed  Google Scholar 

  5. Wityk RJ, Lehman D, Klag M, et al. Race and sex differences in the distribution of cerebral atherosclerosis. Stroke. 1995;27:1974–80.

    Article  Google Scholar 

  6. Bogousslavsky J, Van MG, Regli F. The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke. Stroke. 1988;19:1083–92.

    Article  CAS  PubMed  Google Scholar 

  7. Foulkes MA, Wolf PA, Price TR, Mohr JP, Hier DB. The Stroke Data Bank: design, methods, and baseline characteristics. Stroke. 1988;19:547–54.

    Article  CAS  PubMed  Google Scholar 

  8. Inzitari D, Eliasziw M, Gates P, Sharpe BL, Chan RK, Meldrum HE, et al. The causes and risk of stroke in patients with asymptomatic internal-carotid-artery stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. New Engl J Med. 2000;342:1693–700.

    Article  CAS  PubMed  Google Scholar 

  9. Timsit SG, Sacco RL, Mohr JP, Foulkes MA, Tatemichi TK, Wolf PA, et al. Early clinical differentiation of cerebral infarction from severe atherosclerotic stenosis and cardioembolism. Stroke. 1992;23:486–91.

    Article  CAS  PubMed  Google Scholar 

  10. Hall HA, Bassiouny HS. Pathophysiology of carotid atherosclerosis. In: Nicolaides A et al., editors. Ultrasound and carotid bifurcation atherosclerosis. London: Springer; 2012. p. 27–39.

    Google Scholar 

  11. Fisher CM. Occlusion of the internal carotid artery. Arch Neurol Psychiatr. 1951;65:346–77.

    Article  CAS  Google Scholar 

  12. Fine-Edelstein JS, Wolf PA, O’Leary DH, et al. Precursors of extracranial carotid atherosclerosis in the Framingham Study. Neurology. 1994;44:1046–50.

    Article  CAS  PubMed  Google Scholar 

  13. White H, Boden-Albala B, Wang C, et al. Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation. 2005;111:1327–31.

    Article  PubMed  Google Scholar 

  14. Lisabeth LD, Ireland JK, Risser JM, et al. Stroke risk after transient ischemic attack in a population-based setting. Stroke. 2004;35:1842–6.

    Article  PubMed  Google Scholar 

  15. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade stenosis. New Engl J Med. 1991;325:445–53.

    Article  Google Scholar 

  16. European Carotid Surgery Trialists’ Collaborative Group. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet. 1998;351:1379–87.

    Article  Google Scholar 

  17. Mayberg MR, Wilson SE, Yatsu F, et al. Carotid endarterectomy and prevention of cerebral ischemia in symptomatic carotid stenosis. JAMA. 1991;266:3289–94.

    Article  CAS  PubMed  Google Scholar 

  18. Rothwell PM, Eliasziw M, Gutnikov SA, Fox AJ, Taylor DW, Mayberg MR, et al. Carotid Endarterectomy Trialists’ Collaboration. Analysis of pooled data from the randomised controlled trials of endarterectomy. Lancet. 2003;361(9352):107–16.

    Article  CAS  PubMed  Google Scholar 

  19. Brott TG, Halperin JL, Abbara S, et al. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery Developed in Collaboration With the American Academy of Neurology and Society of Cardiovascular Computed Tomography. J Am Coll Cardiol. 2011;57(8):e16–94. doi:10.1016/j.jacc.2010.11.006.

    Article  PubMed  Google Scholar 

  20. Mathias K. A new catheter system for percutaneous transluminal angioplasty (PTA) of carotid artery stenosis [in German]. Fortschr Med. 1977;95(15):1007–11.

    CAS  PubMed  Google Scholar 

  21. Kerber CW, Cromwell LD, Loehden OL. Catheter dilatation of proximal carotid stenosis during distal bifurcation endarterectomy. Am J Neuroradiol. 1980;1(4):348–9.

    CAS  PubMed  Google Scholar 

  22. CAVATAS Investigators. Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial. Lancet 2001;357(9270):1729–37. 22.

    Google Scholar 

  23. Yadav JS, Wholey MH, Kuntz RE, Fayad P, Katzen BT, Mishkel GJ, et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. New Engl J Med. 2004;351(15):1493–501.

    Article  CAS  PubMed  Google Scholar 

  24. Gurm HS, Yadav JS, Fayad P, Katzen BT, Mishkel GJ, Bajwa TK, et al. Long-term results of carotid stenting versus endarterectomy in high-risk patients. New Engl J Med. 2008;358(15):1572–9.

    Article  CAS  PubMed  Google Scholar 

  25. SPACE Collaborative Group, Ringleb PA, Allenberg J, Bruck-mann H, Eckstein HH, Fraedrich G, et al. 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial. Lancet. 2006;368(9543):1239–47.

    Article  CAS  PubMed  Google Scholar 

  26. Mas JL, Chatellier G, Beyssen B, Branchereau A, Moulin T, Becquemin JP, et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. New Engl J Med. 2006;355(16):1660–71.

    Article  CAS  PubMed  Google Scholar 

  27. Brott TG, Hobson 2nd RW, Howard G, Roubin GS, Clark WM, Brooks W, et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. New Engl J Med. 2010;363(1):11–23.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  28. Meier P, Knapp G, Tamhane U, Chaturvedi S, Gurm HS. Short term and intermediate term comparison of endarterectomy versus stenting for carotid artery stenosis: systematic review and meta-analysis of randomised controlled clinical. Br Med J. 2010;340:c467.

    Article  Google Scholar 

  29. Stablie E, Salemme L, Sorropago G, Tesorio T, Nammas W, et al. Proximal endovsacular occulsion for carotid artery stenting: results from a prospective registry of 1,300 patients. J Am Coll Cardiol. 2010;55(16):1661–7.

    Article  Google Scholar 

  30. Johnston SC, Gress DR, Browner WS, Sidney S. Short term prognosis after emergency department diagnosis of TIA. JAMA. 2000;284:2901–6.

    Article  CAS  PubMed  Google Scholar 

  31. Lovett JK, Dennis MS, Sandercock PAG, Bamford J, Warlow CP, Rothwell PM. Very early risk of stroke after first transient ischemic attack. Stroke. 2003;34:134–42.

    Article  Google Scholar 

  32. Coull A, Lovett JK, Rothwell PM, on behalf of the Oxford Vascular Study. Early risk of stroke after a TIA or minor stroke in a population-based incidence study. Br Med J. 2004;328:326–8.

    Article  CAS  Google Scholar 

  33. Giles MF, Rothwell PM. Risk of stroke after transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol. 2007;6:1063–72.

    Article  PubMed  Google Scholar 

  34. Lovett JK, Coull AJ, Rothwell PM. Early risk of recurrence by subtype of ischaemic stroke in population based incidence studies. Neurology. 2004;62:569–73.

    Article  CAS  PubMed  Google Scholar 

  35. Rothwell PM, Giles MF, FLossman E, Lovelock CE, Redgrave JN, Warlow CP, et al. A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaeimc attack. Lancet. 2005;366:29–36.

    Article  CAS  PubMed  Google Scholar 

  36. Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJM. For the Carotid Endarterectomy Trialists Collaboration. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet. 2004;363:915–24.

    Article  CAS  PubMed  Google Scholar 

  37. Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJM. Sex difference in the effect of time from symptoms to surgery on the benefit from carotid endarterectomy for transient ischaemic attack and minor stroke. Stroke. 2004;35:2855–61.

    Article  CAS  PubMed  Google Scholar 

  38. Liapis CD, Bell PR, Mikhailidis D, Sivenius J, Nicolaides A, Fernandes e Fernandes J, et al. ESVS guidelines. Invasive treatment for carotid stenosis: indications, techniques. Eur J Vasc Endovasc. 2009;37(4 Suppl):1–19.

    Article  CAS  Google Scholar 

  39. The National Stroke Strategy, www.dh.gov.uk/stroke.

  40. Rerkasem K, Rothwell PM. Systematic review of the operative risks of carotid endarterectomy for recently symptomatic stenosis in relation to the timing of surgery. Stroke. 2009;40(10):564–72.

    Article  Google Scholar 

  41. Stromberg S, Gelin J, Osterberg T, Bergstrom GML, Karlstrom L, Osterberg K. Very urgent carotid endarterectomy confers increased procedural risk. Stroke. 2012;43:1331-1335.

    Google Scholar 

  42. Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br Med J. 2002;324:71–86.

    Article  Google Scholar 

  43. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet. 1996;348:1329–39.

    Google Scholar 

  44. Diener HC, Bogousslavsky J, Brass LM, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet. 2004;364:331–7.

    Article  CAS  PubMed  Google Scholar 

  45. Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci. 1996;143:1–13.

    Article  CAS  PubMed  Google Scholar 

  46. Sacco RL, Diener HC, Yusuf S, Cotton D, Ôunpuu S, et al. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. New Engl J Med. 2008;359:1238–51.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  47. Wang Y, Wang Y, Zhao X, Liu L, Wang D, Wnag C, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. New Engl J Med. 2013;369:11–9.

    Article  CAS  PubMed  Google Scholar 

  48. Lindblad B, Persson N, Takolander R, Bergqvist D. Does low dose acetylsalicylic acid prevent stroke after carotid surgery? A double-blind, placebo-controlled randomized trial. Stroke. 1993;24:1125–8.

    Article  CAS  PubMed  Google Scholar 

  49. Taylor DW, Barnett HJM, Haynes RB, Ferguson GG, Sackett DL, Thorpe KE, et al. Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomized controlled trial. Lancet. 1999;353:2179e84.

    Google Scholar 

  50. Payne DA, Jones CI, Hayes PD, Thompson MM, London NJ, Bell PR, et al. Beneficial effects of clopidogrel combined with aspirin in reducing cerebral emboli in patients undergoing carotid endarterectomy. Circulation. 2004;109:1476–81.

    Article  CAS  PubMed  Google Scholar 

  51. McKevitt FM, Randall MS, Cleveland TJ, Gaines PA, Tan KT, Venables GS. The benefits of combined anti-platelet treatment in carotid artery stenting. Eur J Vasc Endovasc. 2005;29:522–7.

    Article  CAS  Google Scholar 

  52. Bhatt DL, Kapadia SR, Bajzer CT, Chew DP, Ziada KM, Mukherjee D, et al. Dual antiplatelet therapy with clopidogrel and aspirin after carotid artery stenting. J Invasive Cardiol. 2001;13(12):767–71.

    CAS  PubMed  Google Scholar 

  53. Grewe PH, Deneke T, Machraoui A, Barmeyer J, Müller KM. Acute and chronic tissue response to coronary stent implantation: pathologic findings in human specimen. J Am Coll Cardiol. 2000;35:157–63.

    Article  CAS  PubMed  Google Scholar 

  54. International Society of Hypertension Writing Group. International Society of Hypertension (ISH): statement on blood pressure lowering and stroke prevention. J Hypertens. 2003;21:651–63.

    Article  Google Scholar 

  55. Cruickshank JM, Fox K, Collins P, et al. Meta-analysis of hypertension treatment trials. Lancet. 1990;335:1092–4.

    Google Scholar 

  56. Lawes CM, Bennet DA, Feigan VL, et al. Blood pressure and stroke: an overview of published reviews. Stroke. 2004;35:776–85.

    Article  PubMed  Google Scholar 

  57. Neal B, MacMahon S, Chapman N. Blood Pressure Lowering Treatment Trialists’ Collaboration. Effects of ACE inhibitors, calcium channel antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Lancet. 2000;356:1955–64.

    Article  CAS  PubMed  Google Scholar 

  58. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358:1033–41.

    Article  Google Scholar 

  59. Briel M, Studer M, Glass TR, et al. Effects of statins on stroke prevention in patients with and without coronary heart disease: a meta-analysis on randomized controlled trials. Am J Med. 2004;117:596–606.

    Article  CAS  PubMed  Google Scholar 

  60. Amarenco P, Bogousslavsky J, Callahan III A, et al. High-dose atorvastatin after stroke or transient ischemic attack. New Engl J Med. 2006;355:549–59.

    Article  CAS  PubMed  Google Scholar 

  61. Sillesen H, Amarenco P, Hennerici MG, et al. Atrovastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2008;39:3297–302.

    Article  CAS  PubMed  Google Scholar 

  62. Heart Protection Collaborative Study Group. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20,536 people with cerebrovascular disease or other high-risk conditions. Lancet. 2004;363:757–67.

    Article  Google Scholar 

  63. McGirt MJ, Perler BA, Brooke BS, Woodworth GF, Coon A, Jain S, et al. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors reduce the risk of perioperative stroke and mortality after carotid endarterectomy. J Vasc Surg. 2005;42:829–36.

    Article  PubMed  Google Scholar 

  64. Durazzo AE, Machado FS, Ikeoka DT, De Bernoche C, Monachini MC, Puech-Leaõ P, et al. Reduction in cardiovascular events after vascular surgery with atorvastatin:a randomized trial. J Vasc Surg. 2004;39:967–76.

    Article  PubMed  Google Scholar 

  65. Schouten O, Kertai MD, Bax JJ, Durazzo AE, Biagini E, Boersma E, et al. Safety of perioperative statin use in high-risk patients undergoing major vascular surgery. Am J Cardiol. 2005;95:658–60.

    Article  CAS  PubMed  Google Scholar 

  66. Groschel K, Ernemann U, Schulz JB, Nägele T, Terborg C, Kastrup A. Statin therapy at carotid angioplasty and stent placement: effect on procedure-related stroke, myocardial infarction, and death. Radiology. 2006;240:145–51.

    Article  PubMed  Google Scholar 

  67. Tadros RO, Vouyouka AG, Chung C, Malik RK, Krishnan P, Ellozy SH, et al. The effect of statin use on embolic potential during carotid angioplasty and stenting. Ann Vasc Surg. 2013;27(1):96–103.

    Article  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Jason Litsky, Erik Stilp, Roland Njoh, and Carlos Mena-Hurtado declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, Fitkin Memorial Pavilion, 789 Howard Avenue 3rd floor, New Haven, CT, 06519, USA

    Jason Litsky, Erik Stilp & Carlos Mena-Hurtado

  2. Department of Internal Medicine, St. Mary’s Hospital, 56 Franklin Street, Waterbury, CT, 06706, USA

    Roland Njoh

Authors
  1. Jason Litsky
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Erik Stilp
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Roland Njoh
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Carlos Mena-Hurtado
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jason Litsky.

Additional information

This article is part of the Topical Collection on Peripheral Vascular Disease

Rights and permissions

Reprints and permissions

About this article

Cite this article

Litsky, J., Stilp, E., Njoh, R. et al. Management of Symptomatic Carotid Disease in 2014. Curr Cardiol Rep 16, 462 (2014). https://doi.org/10.1007/s11886-013-0462-3

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11886-013-0462-3

Keywords

Search

Navigation